BRIEF: Financial asset gains lift XtalPi to profit, as revenue triples
AI drug discovery company XtalPi Holdings Ltd. (2228.HK) announced on Tuesday it expects to report net profit of 100 million yuan ($14 million) or more for 2025, reversing a 1.52…
XtalPi scores landmark deal for AI drug discovery
The biotech has partnered with U.S. firm DoveTree in a collaboration worth up to $5.99 billion, adding to a slew of major deals for Chinese research firms this year Key…
BRIEF: XtalPi acquires British chiral molecule developer
AI drug discovery company XtalPi Holdings Ltd. (2228.HK) said on Thursday it has acquired Liverpool ChiroChem Technologies Ltd. (LCC), a developer of novel molecules specializing in chiral molecules. It did not disclose…
NEWS WRAP: Surging Xtalpi seizes on tech rally to raise $267 million
The Tencent-backed AI drug developer announced a major new fundraising as it steps up its AI project development By Teri Yu AI drug discovery company XtalPi Holdings Ltd. (2228.HK) announced…
BRIEF: XtalPi shares surge on Microsoft China partnership
AI pharmaceutical company XtalPi Holdings Ltd. (2228.HK) on Monday announced it has entered into a strategic cooperation memorandum with Microsoft China for new drug and materials development. Under the tie-up, the…
InSilico seeks IPO boost to get AI drugs over the line
The drug developer has raised around $400 million in seven rounds of financing. But after burning through cash, the company needs fresh capital to sustain its work on AI-assisted drugs…
